Dry AMD Symposium 2

Related

• 

  Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial

  Peter A. Campochiaro, MD

  Updates from the Field

  2021

• 

  ReCLAIM-2: Phase 2 Trial of Subcutaneous Elamipretide in Patients with Noncentral Geographic Atrophy

  Jeffrey S. Heier, MD

  Annual Meeting Talks

  2022

• 

  Episode 4: 3-year Results of the TREX-AMD Trial with Dr. Charles Wykoff

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2017